Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.52 -0.24 (-3.09%) Market Cap: 998.89 Mil Enterprise Value: 999.89 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 80/100

Q4 2022 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Feb 22, 2023 / 10:00PM GMT
Release Date Price: $13.83 (-1.21%)
Operator

Greetings, and welcome to the Fourth Quarter and Year-end 2022 Maravai LifeSciences Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the conference over to our host, Debra Hart, Head of Investor Relations. Thank you. You may begin.

Debra Hart
Maravai LifeSciences Holdings, Inc. - Senior Director of IR

Thank you, Diego. Good afternoon, everyone. Thanks for joining us for our fourth quarter and year-end 2020 earnings call. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com.

As you can see on our agenda for today, on Slide 2, Carl will first provide you with a business update, and Kevin will review our financial results and guidance. Trey Martin, President of Biologics Safety Testing; and Becky Buzzeo, our Chief Commercial Officer, will join the call for the question-and-answer session following the prepared remarks.

We remind you management will make forward-looking statements and refer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot